News | Antiplatelet and Anticoagulation Therapies | November 16, 2017

November 16, 2017 — Bristol-Myers Squibb Company and Pfizer Inc. released real-world data (RWD) of outcomes...

Videos | Left Atrial Appendage (LAA) Occluders | November 14, 2017

Vivek Reddy, M.D., director of cardiac arrhythmia services and professor of medicine, cardiology, Mount Sinai...

Mexican Doctors Safely Reuse Donated Pacemakers After Sterilization
News | Pacemakers | November 10, 2017

November 10, 2017 — Mexican doctors have safely reused donated...

Acutus dipole density EP mapping for ablation procedures.

The FDA recently cleared high-speed Acutus Medical's AcQMap High Resolution image and mapping system and the AcQMap 3-D Imaging and Mapping Catheter.  detects and displays both standard voltage-based and higher resolution dipole density (charge-source) maps. The system combines ultrasound anatomy construction with an ability to map the electrical-conduction of each heartbeat to identify complex arrhythmias across the entire atrial chamber. Following each ablation treatment, the heart can be re-mapped in seconds to continually visualize any changes from the prior mapping.

 

 

Feature | Atrial Fibrillation | November 07, 2017

November 7, 2017 — Here is an aggregated list of articles detailing the latest clinical data and new device...

The Abbott/St. Jude Confirm RX implantable cardiac monitor (ICM) is the first ICM that is compatible with patients' smartphones to eliminate the need for a bedside base unit monitor to transfer data to physicians. Its FDA clearance was in October 2017.

The Abbott/St. Jude Confirm RX implantable cardiac monitor (ICM) is the first ICM that is compatible with patients' smartphones to eliminate the need for a bedside base unit monitor to transfer data to physicians. Its FDA clearance was the No. 1 most popular article on DAIC in October.

Feature | November 03, 2017 | Dave Fornell

November 3, 2017 — Here is the list of the most popular articles and videos on the Diagnostic and Interventional...

The Watchman LAA occluder PREVAIL Trial 5-year results were presented at the 2017 TCT meeting.
Feature | Atrial Fibrillation | November 02, 2017

November 2, 2017 – Five-year results from the PREVAIL Trial comparing left atrial appendage closure (LAAC) with the...

Societies Detail Treatment for Patients With Ventricular Arrhythmias
News | EP Lab | October 30, 2017

October 30, 2017 — The American College of Cardiology, along with the American Heart Association and the Heart...

Videos | EP Mapping and Imaging Systems | October 24, 2017

This video, provided by Acutus Medical, demonstrates a patient case showing the use of the AcQMap high-resolution...

Acutus Medical Receives FDA Clearance for AcQMap Cardiac Mapping Technology
Technology | EP Mapping and Imaging Systems | October 24, 2017

October 24, 2017 — Acutus Medical announced that the U.S. Food and Drug Administration (FDA) has cleared the AcQMap ...

UNC School of Medicine Receives $1.7 Million for Atrial Fibrillation Program Streamlining Patient Care
News | Atrial Fibrillation | October 23, 2017

October 23, 2017 — University of North Carolina (UNC) School of Medicine cardiologist Anil Gehi, M.D., will use a $1...

Abbott SJM St. Jude Confirm RX implantable cardiac monitor (ICM).

The Abbott Confirm RX implantable cardiac monitor (ICM) is smaller than a computer thumb-drive and in implanted in a simple in-office procedure just under the skin.

Technology | Implantable Cardiac Monitor (ICM) | October 23, 2017

October 23, 2017 – The U.S. Food and Drug Administration (FDA) has cleared Abbott’s Confirm Rx Insertable Cardiac...

Trial Data Shows Positive Predictive Results for Boston Scientific HeartLogic Heart Failure Diagnostic
News | Heart Failure | October 20, 2017

October 20, 2017 — Boston Scientific announced new data from the Multisensor Chronic Evaluation in Ambulatory Heart...

Smartphone Apps Help Patients and Providers Manage Atrial Fibrillation
News | Patient Engagement | October 19, 2017

October 19, 2017 — Novel smartphone and tablet applications for atrial fibrillation patients and healthcare...

The Respicardia Remede System is a pacemaker-like device designed to improve cardiovascular health by restoring natural breathing during sleep in patients with Central sleep apnea.
Technology | Heart Failure | October 18, 2017

October 18, 2017 — The U.S. Food and Drug Administration (FDA) recently approved a new treatment option for patients...

Baylis Medical and Siemens Co-Sponsor Transseptal Access Training Course
News | EP Lab | October 18, 2017

October 18, 2017 — Baylis Medical Co. Inc. and Siemens Healthineers are co-sponsoring a first-of-its kind training...

Overlay Init